NCT01487265 2019-03-06Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to ErlotinibSCRI Development Innovations, LLCPhase 2 Completed37 enrolled 10 charts